219 POSTER NVP-BEZ235, a dual pan-PI3K/mTOR kinase inhibitor, is effective in human lung cancer models harboring EGFR mutations
C.R. Schnell, J. Vaxelaire, M. Vogelsanger, M. Hattenberger, F. Stauffer, S. Arnal, C. Garcia-Echeverria, S.M. MairaVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72151-7
File:
PDF, 57 KB
english, 2008